2016 American Transplant Congress
Urinary Neutrophil Gelatinase-Associated Lipocalin in Living Kidney Donor Nephrectomy.
Introduction: Urinary neutrophil gelatinase-associated lipocalin (uNGAL) is a marker for acute kidney injury. This study was conducted to evaluate the efficacy of perioperative uNGAL in…2016 American Transplant Congress
Controlled Cardiac Death Donor Program for Kidney Transplantation – Spanish Multicenter Experience with Two Years of Follow-Up.
Background: Controlled donation after cardiac death (cDCD) programs are running in several countries for years. National transplant organization (ONT) has developed a nation-wide program in…2016 American Transplant Congress
Tumor-Necrosis-Factor-α Antagonist Therapy for Inflammatory Bowel Disease After Liver Transplantation.
Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI.
Background:The safety and effectiveness of tumor-necrosis-factor-α antagonist (anti-TNF-α) therapy for inflammatory bowel disease (IBD) has not been well-established in patients after liver transplantation (LT). We…2016 American Transplant Congress
Japanese Multicenter Study of Hepatopulmonary Syndrome in Living Donor Liver Transplantation.
Surgery, Tokyo Women's Medical University, Tokyo, Japan.
It is well known that hepatopulmonary syndrome (HPS) manifested with hypo-oxygenemia secondary to intra-pulmonary shunt has negative impacts on outcomes of liver transplantation in deceased…2016 American Transplant Congress
Single Center Experience with Robotic Kidney Transplantation for Recipients with BMI >40 kg/m2: A Comparison with the UNOS Registry.
Surgery, University of Illinois, Chicago, IL.
Introduction:Obesity represents a barrier to kidney transplantation, but the increasing prevalence amongst renal failure patients has forced some centers to carefully consider such candidates. Morbidly…2016 American Transplant Congress
Predictors of Urologic Complications After Pediatric En-Bloc Donor Kidney Transplantation.
Pediatric en-bloc kidney transplant (PEBKT) has expanded the donor pool. Association of donor characteristics and urologic complications is not well described. The objective of this…2016 American Transplant Congress
The Effect of Immunosuppression Regimen on Iga Nephropathy Recurrence Post Kidney Transplantation.
Background: Steroid sparing immunosuppression is increasingly used in order to avoid the many well-known side effects of steroids. It has been argued that steroid use…2016 American Transplant Congress
Comparative Effectiveness of Cytomegalovirus Prevention Strategies in a Large Retrospective Cohort of Kidney Transplant Recipients.
Washington University School of Medicine, Saint Louis, MO.
Background: While CMV prevention strategies have been studied in carefully selected groups of patients enrolled in randomized trials, their comparative effectiveness in real-world settings is…2016 American Transplant Congress
Neuro-invasive Saint Louis Encephalitis Virus (SLEV) Infection in Solid Organ Transplant Recipients in a Non-Endemic Area.
Infectious Disease, Mayo Clinic Arizona, Phoenix, AZ.
Background:In the summer of 2015, three prior solid organ transplant recipients developed meningoencephalitis suggestive of West Nile virus (WNV) infection in the Phoenix area with…2016 American Transplant Congress
Donor Specif Antibody (DSA) Kinetics in Patients with Antibody Mediated Rejection (AMR) Treated with Plasmapheresis and Bortezomib.
Backgroud: The best choice to treat AMR is not supported by several evidences, and recently the interest in drugs as Bortezomib has improved. Aim: Evaluted…
- « Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 180
- Next Page »